Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening

Annals of Hematology

Volumn 95, Issue 3, 2016, Pages 397-402

  Kunz, Joachim B ^a   Awad, Saida ^a   Happich, Margit ^a   Muckenthaler, Lena ^a   Lindner, Martin ^a,b   Gramer, Gwendolyn ^a   Okun, Jürgen G ^a   Hoffmann, Georg F ^a   Bruckner, Thomas ^a   Muckenthaler, Martina U ^a   Kulozik, Andreas E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Allele specific PCR; Newborn screening; Prevalence; Sickle cell disease

Indexed keywords

HEMOGLOBIN BETA CHAIN; HEMOGLOBIN S;

ALLELE; ARTICLE; COHORT ANALYSIS; DRIED BLOOD SPOT TESTING; GENE MUTATION; GERMANY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RURAL POPULATION; SENSITIVITY AND SPECIFICITY; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; SICKLE CELL TRAIT; URBAN POPULATION; ANEMIA, SICKLE CELL; FEMALE; GENETICS; MALE; PREVALENCE; PROCEDURES;

ANEMIA, SICKLE CELL; COHORT STUDIES; DRIED BLOOD SPOT TESTING; FEMALE; GERMANY; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PREVALENCE; SICKLE CELL TRAIT;

EID: 84957433596     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-015-2573-y     Document Type: Article

References (30)

1. Thornburg CD, Files BA, Luo Z, Miller ST, Kalpatthi R, Iyer R, Seaman P, Lebensburger J, Alvarez O, Thompson B, Ware RE, Wang WC (2012) Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood 120(22):4304–4310. doi:10.1182/blood-2012-03-419879
2. Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW, investigators BH, (2011) Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 377(9778):1663–1672. doi:10.1016/S0140-6736(11)60355-3
3. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, Pegelow CH, Vichinsky E (1995) Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell disease. Blood 86(2):776–783
4. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B (1988) Newborn screening for sickle cell disease: effect on mortality. Pediatrics 81(6):749–755
5. Bain BJ (2009) Neonatal/newborn haemoglobinopathy screening in Europe and Africa. J Clin Pathol 62(1):53–56. doi:10.1136/jcp.2008.060624
6. Bardakdjian-Michau J, Bahuau M, Hurtrel D, Godart C, Riou J, Mathis M, Goossens M, Badens C, Ducrocq R, Elion J, Perini JM (2009) Neonatal screening for sickle cell disease in France. J Clin Pathol 62(1):31–33. doi:10.1136/jcp.2008.058867
7. Giordano PC (2009) Starting neonatal screening for haemoglobinopathies in The Netherlands. J Clin Pathol 62(1):18–21. doi:10.1136/jcp.2008.058826
8. Gulbis B, Cotton F, Ferster A, Ketelslegers O, Dresse MF, Ronge-Collard E, Minon JM, Le PQ, Vertongen F (2009) Neonatal haemoglobinopathy screening in Belgium. J Clin Pathol 62(1):49–52. doi:10.1136/jcp.2008.060517
9. Rahimy MC, Gangbo A, Ahouignan G, Alihonou E (2009) Newborn screening for sickle cell disease in the Republic of Benin. J Clin Pathol 62(1):46–48. doi:10.1136/jcp.2008.059113
10. Streetly A, Latinovic R, Hall K, Henthorn J (2009) Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005–7. J Clin Pathol 62(1):26–30. doi:10.1136/jcp.2008.058859
11. Tshilolo L, Aissi LM, Lukusa D, Kinsiama C, Wembonyama S, Gulbis B, Vertongen F (2009) Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. J Clin Pathol 62(1):35–38. doi:10.1136/jcp.2008.058958
12. Dickerhoff R, Genzel-Boroviczeny O, Kohne E (2009) Haemoglobinopathies and newborn haemoglobinopathy screening in Germany. J Clin Pathol 62(1):34. doi:10.1136/jcp.2008.058909
13. Lobitz S, Frommel C, Brose A, Klein J, Blankenstein O (2014) Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany. European journal of human genetics: EJHG. doi:10.1038/ejhg.2013.286
14. Grosse R, Lukacs Z, Cobos PN, Oyen F, Ehmen C, Muntau B, Timmann C, Noack B (2015) The prevalence of sickle cell disease and its implication for newborn screening in Germany (Hamburg metropolitan area). Pediatric blood & cancer. doi:10.1002/pbc.25706
15. Kohne E, Kleihauer E (2010) Hemoglobinopathies: a longitudinal study over four decades. Deutsch Arztebl Int 107(5):65–71. doi:10.3238/arztebl.2010.0065
16. Piel FB, Tatem AJ, Huang Z, Gupta S, Williams TN, Weatherall DJ (2014) Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000. Lancet Global Health 2(2):e80–e89. doi:10.1016/s2214-109x(13)70150-5
17. Eastman JW, Wong R, Liao CL, Morales DR (1996) Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies. Clin Chem 42(5):704–710
18. Murray C, Hall SK, Griffiths P (2011) An evaluation of the Sebia capillarys Neonat Haemoglobin FAST system for routine newborn screening for sickle cell disease. Int J Lab Hematol 33(5):533–539. doi:10.1111/j.1751-553X.2011.01315.x
19. Frommel C, Brose A, Klein J, Blankenstein O, Lobitz S (2014) Newborn screening for sickle cell disease: technical and legal aspects of a German pilot study with 38,220 participants. BioMed Res Int 2014:695828. doi:10.1155/2014/695828
20. Uta Nennstiel-Ratzel AL, Oliver Blankenstein, Uta Ceglarek, Regina Ensenauer,, Christoph Fusch JK, Martin Lindner, Cornelia Müller, Michael Peter,, Joachim G. Kreuder WR, Wolfgang Schultis, Andreas Schulze, Sabine, Rönicke MS, Marina Stopsack, Sylvia Zollikofer, Klaus Mohnike (2012) Nationaler Screeningreport Deutschland 2012
21. Manu Pereira M, Corrons JL (2009) Neonatal haemoglobinopathy screening in Spain. J Clin Pathol 62(1):22–25. doi:10.1136/jcp.2008.058834
22. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G (1995) Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ 311(7020):1600–1602
23. Yanni E, Grosse SD, Yang Q, Olney RS (2009) Trends in pediatric sickle cell disease-related mortality in the United States, 1983–2002. J Pediatr 154(4):541–545. doi:10.1016/j.jpeds.2008.09.052
24. Olney RS (1999) Preventing morbidity and mortality from sickle cell disease. A public health perspective. Am J Prev Med 16(2):116–121
25. Bundesausschuss der Ärzte und Krankenkassen (1976, revised 2010) Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die Früherkennung von Krankheiten bei Kindern bis zur Vollendung des 6. Lebensjahres (“Kinder-Richtlinien”). Available from: https://www.g-ba.de/downloads/62-492-506/RL_Kinder_2010-12-16.pdf
26. WorldHealthOrganisation (2006) Sickle cell anaemia. Agenda item 114 In: 59th World Health Assembly, 27 May 2006 WHA 5920. Available from: http://www.who.int/gb/ebwha/pdf_files/WHA59-REC1/e/WHA59_2006_REC1-en.pdf
27. Cai SP, Eng B, Francombe WH, Olivieri NF, Kendall AG, Waye JS, Chui DH (1992) Two novel beta-thalassemia mutations in the 5′ and 3′ noncoding regions of the beta-globin gene. Blood 79(5):1342–1346
28. Li HJ, Zhao XN, Li HW, Li L, Liang KX, Wang RP, Chang TT, Wilson JB, Webber BB, Huisman TH (1990) A new slow-moving hemoglobin variant Hb Tianshui or alpha 2 beta(2)39(C5)Gln----Arg, observed in a Chinese family living in Gansu. Hemoglobin 14(5):569–570
29. Li HJ, Zhao XN, Qin F, Li HW, Li L, He XJ, Chang XS, Li ZM, Liang KX, Xing FL et al (1990) Abnormal hemoglobins in the Silk Road region of China. Hum Genet 86(2):231–235
30. Brimhall B, Jones RT, Schneider RG, Hosty TS, Tomlin G, Atkins R (1975) Two new hemoglobins. Hemoglobin Alabama (beta39(C5)Gln leads to Lys) and hemoglobin Montgomery (alpha 48(CD 6) Leu leads to Arg). Biochim Biophys Acta 379(1):28–32